Mezun Olduğu Tıp Fakültesi ve Yılı

Ege Üniversitesi Tıp Fakültesi, 1992-1998
 

Uzmanlık Eğitimi Aldığı Yer ve Yılı

Dokuz Eylül Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisi, 2000-2006
 

Mesleki Deneyim

Radyasyon Onkolojisi Uzmanı, Samsun Eğitim ve Araştırma Hastanesi Radyasyon Onkolojisi Kliniği, 2006-2010

Radyasyon Onkolojisi Yardımcı Doçenti, Radyasyon Onkolojisi Anabilim Dalı, Eskişehir, 2010-2016

Radyasyon Onkolojisi Doçenti, Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı ve FMV Işık Üniversitesi MYO, 2016-2021

Radyasyon Onkolojisi Profesörü, İstanbul Medipol Üniversitesi Radyasyon Onkolojisi Anabilim Dalı, 2025-2026

Radyasyon Onkolojisi Uzmanı, Medicana International İstanbul Hastanesi, 2026-Halen
 

Tıbbi İlgi Alanları

Baş ve Boyun Kanserleri

Ürogenital Kanserler

Akciğer Kanseri

Geriatrik Onkoloji

Psikoonkoloji

Stereotaktik Radyoterapi

Palyatif ve Destek Bakım

Bilimsel Yayınlar

1. Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.

2. Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.

3. Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.

4. Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.

5. Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.

6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.

7. Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.

8. Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.

9. Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.

10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.

11. Metcalfe E, Aspin L, Speight R, et al. Postoperative (Chemo)Radiotherapy for Oral Cavity Squamous Cell Carcinomas: Outcomes and Patterns of Failure. Clin Oncol (R Coll Radiol). 2017;29(1):51-59.

12. Etiz D, Metcalfe E, Akcay M. Multiple Primary Malignant Neoplasms: A 10-Year Experience at a Single Institution from Turkey. J Cancer Res Ther. 2017;13(1):16-20.

13. Metcalfe E, Arik D, Oge T, et al. CD105 (Endoglin) Expression as a Prognostic Marker of Angiogenesis in Squamous Cell Cervical Cancer Treated with Radical Radiotherapy. J Cancer Res Ther. 2018;14(6):1373-1378.

14. Oktay E, Levent M, et al. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2020;35(1):69-75.

15. Sert F, Metcalfe E, et al. Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study. Turk J Oncol. 2023;38(3):295-300. DOI:10.5505/tjo.2023.3978.

16. Guzeloz Z, Gorken IB, et al. Evaluation of Treatment Outcomes and Tolerability in Older Patients with Rectal Cancer Treated with Radiotherapy Accompanied by the G-8 Geriatric Score: TROD13-003 Multicenter Study. J Geriatr Oncol. 2024;15(3):101739.

17. Cetin IA, Halis H, et al. Definitive Radiotherapy/Chemoradiotherapy Outcomes and Toxicity Profile in Geriatric Patients with Cervical Cancer: Turkish Society for Radiation Oncology Geriatric Oncology Group Study (TROD 013-002). European Journal of Gynaecological Oncology. 2025;46(11):49-59. DOI:10.22514/ejgo.2025.137.

18. Çağlar M, Akçay K, et al. Surface Dose Analysis and Dosimetric Comparison of Halcyon Versus Truebeam in Breast Cancer Radiotherapy: An OSL Dosimetry Study. J Appl Clin Med Phys. 2025:e70085. DOI:10.1002/acm2.70085.

19. Çağlar M, Ertaş KS, et al. Synthetic CT Generation from CBCT Using Deep Learning for Adaptive Radiotherapy in Prostate Cancer. Front Radiol. 2025;5:1680803.

20. Kirli Bolukbas M, Metcalfe E, et al. Determining Elderly-Friendly Radiation Oncology Clinics: A Comparative Analysis of Accessibility and Transport, Physical Environment, and Privacy Aspects (TROD 013-005). BMC Geriatr. 2025;26(1):118.

21. Ergen ŞA, Dinçbaş FÖ, Metcalfe E, et al. Failure Patterns and the Influence of the TNM Staging Systems on Prognosis in Limited Disease Small Cell Lung Cancer (SCLC): The Turkish Oncology Group (TOG) Study. Clin Transl Oncol. 2025. DOI:10.1007/s12094-025-04092-9.

İkinci Görüş Alın

hastane
Sizi Arayalım
Bize Ulaşın